Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study

Fig. 3

Risk reclassification among AECOPD patients. Estimated risk of death for each patient by the basic model (x-axis) and the enhanced model that also included copeptin (y-axis). “Reclassified up” or “reclassified down” represents an increased or decreased risk of death predicted by the enhanced model as compared to the basic model. The prediction model is improved when survivors are reclassified down, and non-survivors are reclassified up

Back to article page